Studies conducted in A549 human adenocarcinoma cells showed that CAV1 expression was upregulated after incubation with Paclitaxel [54], suggesting that continuous exposure to Paclitaxel can lead to a drug-resistant phenotype at least in part through upregulation of CAV1. Here, CAV1 is linked to adenocarcinoma.